IP Library Granted Patent US 6,962,785
Granted Patent B2
US 6,962,785 · App. 10/212,905 · Granted Nov 8, 2005

Antibacterial and antiviral agents and methods of screening for the same

Assignee: North Carolina State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,962,785
App. No.
10/212,905
Granted
Nov 8, 2005
Kind
B2
Abstract

A method of screening for compounds useful for inhibiting retrovirus propagation in a host for the retrovirus, wherein the retrovirus primes reverse transcription in the host by binding of a specific host tRNA to retrovirus RNA at at least a pair of separate binding sites on the host tRNA, comprises contacting the specific host tRNA to the retrovirus RNA in the presence of the test compound, and then determining whether the compound inhibits the binding of the specific host tRNA to the retrovirus RNA in the presence of the test compound.

Claims (15)

1. A method of screening for compounds useful for inhibiting retrovirus propagation in a host for said retrovirus, wherein said retrovirus primes reverse transcription in said host by binding of a specific host tRNA to retrovirus RNA at a pair of separate binding sites on said host tRNA,

said method comprising:

contacting in vitro said specific host tRNA to said retrovirus RNA in the presence of said test compound; and then;

determining whether said test compound inhibits the binding of said specific host tRNA to said retrovirus RNA;

the inhibition of binding indicating said test compound is useful for inhibiting propagation of said virus in said host;

whereby mutation of said retrovirus RNA to bind an alternate host tRNA for priming of reverse transcription requires a pair of mutations at a pair of separate tRNA binding sites in said retrovirus RNA.

2. A method according to claim 1 , wherein said determining step comprises determining whether said compound inhibits the binding of said tRNA to said retrovirus RNA at position 27-43 of said tRNA.

3. A method according to claim 1 , wherein said specific host tRNA is tRNA lys suu .

4. A method according to claim 3 , wherein said determining step comprises determining whether said compound inhibits the binding of tRNA lys suu at position 34 thereof to said retrovirus RNA.

5. A method of screening for compounds useful for inhibiting retrovirus propagation in a host for said retrovirus, wherein said retrovirus primes reverse transcription in said host by binding of a specific host tRNA to retrovirus RNA at a pair of separate binding sites on said host tRNA, wherein said specific host tRNA is tRNA lys suu ;

said method comprising:

contacting in vitro said specific host tRNA to said retrovirus RNA in the presence of said test compound; and then;

determining whether said compound inhibits the binding of said specific host tRNA to said retrovirus RNA at position 27-43 of said tRNA in the presence of said test compound;

the inhibition of binding indicating said test compound is useful for inhibiting propagation of said virus in said host;

whereby mutation of said retrovirus RNA to bind an alternate host tRNA for priming of reverse transcription requires a pair of mutations at a pair of separate tRNA binding sites in said retrovirus RNA.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 12, 2014
From: OFFICE OF TECHNOLOGY TRANSFER / NORTH CAROLINA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033520/0997 →
Continuity (3)
Continuation 0931567400 · May 20, 1999
Provisional Application 6008638000 · May 22, 1998
Related Publication 20030008808A1 · Jan 9, 2003